Advances in understanding the genomic landscape of haematological disorders mean that we are closer than ever to a precision medicine approach to managing individual patients.
Improved understanding of molecular diagnostics to inform decision-making in treatment selection and prognosis is a priority for health care practitioners.
You will hear from experts discussing recent advances in the genomic classification of myeloproliferative neoplasms, acute lymphoblastic leukemia, lymphoma and marrow failure. This symposium aims to improve your genomic literacy and prepare you for the future of precision oncology for haematological malignancies.
Friday 27 March 2020
9.00am - 4.00pm
Walter & Eliza Hall Institute of Medical Research